Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Other Accumulated Expenses (2020)

Updated

Global Innovative Platforms (GIPL) recorded Other Accumulated Expenses of $17,500 in fiscal Q1 2021 (quarter ended Dec 31, 2020).

Analysis

Global Innovative Platforms (GIPL) Other Accumulated Expenses (2020) Analysis & Trends

At the end of FY2020 (ended Sep 30, 2020), Global Innovative Platforms reported Other Accumulated Expenses of $2,500.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 17,500.00
API Access

Global Innovative Platforms Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GIPL&period=max&api_key=YOUR_API_KEY